Cytex Therapeutics

company

About

Cytex Therapeutics develops bio-artificial devices to treat osteoarthritis and other musculoskeletal diseases.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$149.99K
Industries
Biotechnology
Founded date
Jan 1, 2006
Number Of Employee
1 - 10
Operating Status
Active

Cytex Therapeutics was formed to develop and commercialize the tissue regeneration technology discoveries coming out of the lab of Dr. Farshid Guilak at Duke University. The original Cytex business plan received numerous innovation awards, including seed capital for the startup phase. Since its founding, Cytex has gone on to win numerous state and federal grants, each recognizing the novelty of the research and its enormous potential contribution to the clinical management of patients with osteoarthritis. The three Cytex co-founders form the core leadership of the company as it continues to develop its novel products.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$149.99K
Cytex Therapeutics has raised a total of $149.99K in funding over 2 rounds. Their latest funding was raised on May 28, 2013 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 28, 2013 Grant $149.99K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Cytex Therapeutics is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant